MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

22nd-Nov-2012 11:36Source: BSE

Aurobindo Pharm - Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 22, 2012, titled "Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)."

Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Unilever open offer price for HUL `fair, reasonable`: Panel. Do you think this deal will be beneficial for HUL?
Yes
No